Position in AMGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,683,860,144
+$254,630,275 QoQ
Shares Held
15,696,068
+1.7% QoQ
Ownership
2.90%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#6
of 3,149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $76,028,444,777 across 14 Drug Manufacturers - General names. AMGN ranks #5 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,310,858 | $24,361,454,441 | |
| 2 | JNJ |
Johnson & Johnson
|
59,086,417 | $15,006,177,324 | |
| 3 | ABBV |
AbbVie Inc.
|
46,998,433 | $11,826,685,679 | |
| 4 | MRK |
Merck & Co., Inc.
|
60,744,214 | $7,805,631,499 | |
| 5 | AMGN |
Amgen Inc
This page
|
15,696,068 | $5,683,860,144 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
30,065,642 | $3,798,493,209 | |
| 7 | PFE |
Pfizer Inc
|
135,275,782 | $3,257,440,829 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
56,443,077 | $3,252,250,096 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,683,860,144 | 15,696,068 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $5,429,229,869 | 15,430,524 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,681,611,158 | 14,303,294 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $3,744,092,733 | 13,267,515 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $3,634,928,051 | 13,018,617 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $3,965,204,645 | 12,727,346 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,251,492,340 | 12,475,032 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $3,906,116,064 | 12,122,889 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,755,348,422 | 12,019,038 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $3,310,425,330 | 11,643,308 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,554,154,127 | 12,339,956 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,262,072,081 | 12,137,491 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,619,654,609 | 11,799,183 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,763,265,113 | 11,430,259 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,987,678,916 | 11,375,567 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,524,658,742 | 11,200,793 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,602,824,859 | 10,698,006 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,611,295,930 | 10,798,511 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,300,946,141 | 10,227,791 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,203,502,691 | 10,362,110 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $2,436,079,912 | 9,994,174 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,408,587,788 | 9,680,430 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,023,582,479 | 8,801,246 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $2,331,235,325 | 9,172,314 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,365,552,445 | 10,029,477 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $2,051,060,158 | 10,117,201 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||